Table I.
Clinicopathological characteristics, DCE-MRI parameters and immunohistochemical findings of patients with oral squamous cell carcinoma.
| Number | Age | Sex | Region | TNM | CI-max | T-max | CI-peak | CI-gain | MVD | VEGF | PD-L1 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 65 | M | Maxilla | T1N0M0 | 1.00 | 43.60 | 0.90 | 0.57 | 49.25 | 89.90 | PD-L1+low |
| 2 | 58 | M | Tongue | T1N0M0 | 1.61 | 89.90 | 1.45 | 0.82 | 24.80 | 71.70 | PD-L1+low |
| 3 | 68 | M | Mouth floor | T1N0M0 | 1.17 | 59.70 | 1.05 | 1.02 | 73.80 | 58.30 | PD-L1+high |
| 4 | 55 | M | Tongue | T1N0M0 | 2.28 | 29.30 | 2.05 | 1.14 | 73.40 | 99.50 | PD-L1+high |
| 5 | 77 | F | Mandibular | T2N0M0 | 1.04 | 87.20 | 0.93 | 0.59 | 42.00 | 93.80 | PD-L1− |
| 6 | 65 | F | Mandibular | T2N0M0 | 1.33 | 87.20 | 1.20 | 0.49 | 32.00 | 97.00 | PD-L1− |
| 7 | 34 | F | Tongue | T2N0M0 | 1.51 | 60.10 | 1.36 | 1.23 | 5.20 | 89.30 | PD-L1− |
| 8 | 54 | M | Tongue | T2N0M0 | 1.29 | 75.00 | 1.16 | 0.80 | 29.40 | 46.90 | PD-L1− |
| 9 | 70 | M | Tongue | T2N0M0 | 1.13 | 59.90 | 1.02 | 0.73 | 38.80 | 4.50 | PD-L1− |
| 10 | 63 | M | Mouth floor | T2N0M0 | 0.81 | 45.00 | 0.73 | 0.55 | 22.40 | 14.80 | PD-L1− |
| 11 | 53 | M | Tongue | T2N0M0 | 1.06 | 74.90 | 0.95 | 0.74 | 80.60 | 84.90 | PD-L1− |
| 12 | 59 | M | Mouth floor | T2N0M0 | 1.19 | 89.80 | 1.07 | 0.80 | 31.40 | 15.80 | PD-L1− |
| 13 | 71 | F | Tongue | T2N0M0 | 1.06 | 43.80 | 0.95 | 0.77 | 67.80 | 84.00 | PD-L1+low |
| 14 | 41 | M | Tongue | T2N0M0 | 0.98 | 58.10 | 0.88 | 0.55 | 89.00 | 35.60 | PD-L1+low |
| 15 | 68 | F | Mandibular | T2N0M0 | 1.16 | 44.90 | 1.05 | 1.17 | 56.80 | 75.10 | PD-L1+low |
| 16 | 64 | M | Palate | T2N0M0 | 2.10 | 29.00 | 1.89 | 1.12 | 81.40 | 99.00 | PD-L1+low |
| 17 | 87 | M | Buccal | T2N0M0 | 1.36 | 72.60 | 1.23 | 0.73 | 37.20 | 39.70 | PD-L1+high |
| 18 | 66 | F | Buccal | T2N0M0 | 3.09 | 44.40 | 2.78 | 2.59 | 67.40 | 1.50 | PD-L1+high |
| 19 | 72 | F | Mouth floor | T2N2bM0 | 2.62 | 29.20 | 2.36 | 2.42 | 71.00 | 4.70 | PD-L1+high |
| 20 | 83 | F | Maxilla | T2N2bM0 | 2.13 | 135.10 | 1.92 | 1.28 | 86.40 | 91.40 | PD-L1+high |
| 21 | 76 | F | Maxilla | T3N0M0 | 0.56 | 101.80 | 0.50 | 0.34 | 30.20 | 93.10 | PD-L1− |
| Mean | 64 | 1.45 | 64.79 | 1.31 | 0.97 | 51.92 | 61.45 | ||||
| SD | 13 | 0.64 | 27.26 | 0.57 | 0.57 | 24.65 | 34.97 | ||||
| Median | 65 | 1.19 | 59.90 | 1.07 | 0.80 | 49.25 | 75.10 |
DCE-MRI, dynamic contrast-enhanced magnetic resonance imaging; MVD, microvessel density; VEGF, vascular endothelial growth factor; PD-L1; programmed death ligand-1; PD-L1−, negative PD-L1; PD-L1+low, low-positive PD-L1; PD-L1+high, high-positive PD-L1; M, male; F, female; SD, standard deviation.